dr. bruix on the phase iii resorce trial in hcc
Published 7 years ago • 165 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
2:20
dr. bruix discusses the updated findings of the resorce trial in hcc
-
2:04
dr. bruix on regorafenib in second-line hcc
-
1:28
dr. jordi bruix on efficacy and safety of regorafenib in hcc after sorafenib
-
2:02
dr. bruix discusses the application of regorafenib in hcc
-
0:58
the significance of the resorce trial in hcc
-
1:38
dr. finn on significance of phase iii findings of lenvatinib in hcc
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
1:22
dr. cheng on phase iii findings of lenvatinib in hcc
-
5:10
understanding the resorce data in second-line hcc
-
1:24
phase iii findings for lenvatinib in hcc
-
3:00
ongoing clinical trials in second-line hcc
-
5:22
impact of resorce findings on hcc clinical practice
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
0:58
dr. abou-alfa on significance of resorce trial for hcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
1:35
dr. mirza on the phase iii nova trial in ovarian cancer
-
0:49
dr. daniele on impact of regorafenib in hcc
-
1:52
dr. bekaii-saab discusses the fda approval of lenvatinib in hcc
-
7:38
frontline clinical trials in liver cancer